Discover open access scientific publications

Search, annotate, share and cite publications

Publications by MASARU KOMIYAMA

YKL-40 Downregulation Is a Key Factor to Overcome Temozolomide Resistance in a Glioblastoma Cell Line

Oncology Reports

Cancer Research

English

Related publications

Metformin and Temozolomide, a Synergic Option to Overcome Resistance in Glioblastoma Multiforme Models

English

Chronic Physiological Hypoxia and High Glucose Concentration Promote Resistance of T98G Glioblastoma Cell Line to Temozolomide

Drug Designing: Open Access

English

YKL-40 Expression Is Associated With Poorer Response to Radiation and Shorter Overall Survival in Glioblastoma

Clinical Cancer Research

Cancer Research

English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications

Molecular Biology

English

Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma

Neurologia Medico-Chirurgica

English

Targeting Tumor Associated Macrophages to Overcome Conventional Treatment Resistance in Glioblastoma

Frontiers in Pharmacology

English

Augmented HR Repair Mediates Acquired Temozolomide Resistance in Glioblastoma

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Genetic Alterations Associated With Acquired Temozolomide Resistance in SNB-19, a Human Glioma Cell Line

Molecular Cancer Therapeutics

Cancer Research

English

Epidermal Growth Factor (EGF) Induces a Phenotypic Switch of a Human Glioblastoma Cell Line to Neurospheres

Microscopy and Microanalysis

Instrumentation

English